• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在微流控装置中培养的 Caco-2 细胞中药物的肠道通透性。

Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices.

机构信息

Department of Applied Pharmaceutics and Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyoto University.

Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University.

出版信息

Biol Pharm Bull. 2022;45(9):1246-1253. doi: 10.1248/bpb.b22-00092.

DOI:10.1248/bpb.b22-00092
PMID:36047192
Abstract

Microfluidic devices are attracting attention for their ability to provide a biomimetic microenvironment wherein cells are arranged in a particular pattern and provided fluidic and mechanical forces. In this study, we evaluated drug transport across Caco-2 cell layers in microfluidic devices and investigated the effects of fluid flow on drug transport and metabolism. We designed a microfluidic device that comprises two blocks of polydimethylsiloxane and a sandwiched polyethylene terephthalate membrane with pores 3.0 µm in diameter. When cultured in a dynamic fluid environment, Caco-2 cells were multilayered and developed microvilli on the surface as compared with a static environment. Drugs with higher lipophilicity exhibited higher permeability across the Caco-2 layers, as well as in the conventional method using Transwells, and the fluidic conditions had little effect on permeability. In the Caco-2 cell layers cultured in Transwells and microfluidic devices, the basal-to-apical transport of rhodamine 123, a substrate of P-glycoprotein, was greater than the apical-to-basal transport, and the presence of tariquidar, an inhibitor of P-glycoprotein, completely diminished asymmetric transport. Furthermore, fluidic conditions promoted the metabolism of temocapril by carboxylesterases. On the other hand, we showed that fluidic conditions have little effect on gene expression of several transporters and metabolic enzymes. These results provide useful information regarding the application of microfluidic devices in drug transport and metabolism studies.

摘要

微流控装置因其能够提供仿生微环境的能力而受到关注,在这种微环境中,细胞以特定的模式排列,并提供流体和机械力。在这项研究中,我们评估了微流控装置中 Caco-2 细胞层的药物转运,并研究了流体流动对药物转运和代谢的影响。我们设计了一种微流控装置,由两块聚二甲基硅氧烷和夹在中间的聚对苯二甲酸乙二醇酯膜组成,膜上有 3.0 µm 直径的孔。与静态环境相比,在动态流体环境中培养的 Caco-2 细胞是多层的,并在表面形成微绒毛。亲脂性较高的药物在 Caco-2 层中的渗透性更高,无论是在使用 Transwells 的传统方法中,还是在流体条件下,渗透性都没有太大影响。在 Transwells 和微流控装置中培养的 Caco-2 细胞层中,罗丹明 123(P-糖蛋白的底物)从基底到顶部分泌的转运大于从顶到底部的转运,而 P-糖蛋白抑制剂 tariquidar 完全消除了不对称转运。此外,流体条件促进了 temocapril 被羧基酯酶代谢。另一方面,我们表明流体条件对几种转运体和代谢酶的基因表达影响很小。这些结果为微流控装置在药物转运和代谢研究中的应用提供了有用的信息。

相似文献

1
Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices.在微流控装置中培养的 Caco-2 细胞中药物的肠道通透性。
Biol Pharm Bull. 2022;45(9):1246-1253. doi: 10.1248/bpb.b22-00092.
2
Microfluidic Gut-liver chip for reproducing the first pass metabolism.用于重现首过代谢的微流控肠-肝芯片
Biomed Microdevices. 2017 Mar;19(1):4. doi: 10.1007/s10544-016-0143-2.
3
A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies.使用 Caco-2 细胞的多腔室微流控肠屏障模型用于药物传输研究。
PLoS One. 2018 May 10;13(5):e0197101. doi: 10.1371/journal.pone.0197101. eCollection 2018.
4
Microfluidic gut-on-a-chip with three-dimensional villi structure.具有三维绒毛结构的微流控肠道芯片
Biomed Microdevices. 2017 Jun;19(2):37. doi: 10.1007/s10544-017-0179-y.
5
Head-to-Head Comparison of Caco-2 Transwell and Gut-on-a-Chip Models for Assessing Oral Peptide Formulations.Caco-2 透室与肠道芯片模型对头对头比较,用于评估口服肽制剂。
Mol Pharm. 2024 Aug 5;21(8):3880-3888. doi: 10.1021/acs.molpharmaceut.4c00210. Epub 2024 Jun 28.
6
Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs.验证 Caco-2 微流控芯片模型预测 BCS Ⅰ-Ⅳ类药物肠吸收的能力。
Int J Pharm. 2024 May 10;656:124089. doi: 10.1016/j.ijpharm.2024.124089. Epub 2024 Apr 8.
7
Permeability of rhynchophylline across human intestinal cell in vitro.钩藤碱在体外对人肠细胞的通透性
Int J Clin Exp Pathol. 2014 Apr 15;7(5):1957-66. eCollection 2014.
8
Microfluidic chip for culturing intestinal epithelial cell layers: Characterization and comparison of drug transport between dynamic and static models.用于培养肠上皮细胞层的微流控芯片:动态和静态模型之间药物传输的特性描述和比较。
Toxicol In Vitro. 2020 Jun;65:104815. doi: 10.1016/j.tiv.2020.104815. Epub 2020 Feb 29.
9
Towards embedding Caco-2 model of gut interface in a microfluidic device to enable multi-organ models for systems biology.致力于将肠道界面的Caco-2模型嵌入微流控装置,以实现用于系统生物学的多器官模型。
BMC Syst Biol. 2019 Mar 5;13(Suppl 1):19. doi: 10.1186/s12918-019-0686-y.
10
Analysis of Non-linear Pharmacokinetics of P-Glycoprotein Substrates in a Microfluidic Device Using a Mathematical Model that Includes an Unstirred Water Layer (UWL) Compartment.基于包含非搅拌水层(UWL)隔室的数学模型分析在微流控装置中 P-糖蛋白底物的非线性药代动力学。
Pharm Res. 2021 Jun;38(6):1031-1039. doi: 10.1007/s11095-021-03054-4. Epub 2021 May 19.

引用本文的文献

1
Evaluation of Perfusion Cell Culture Conditions in a Double-Layered Microphysiological System Using AI-Assisted Morphological Analysis.使用人工智能辅助形态学分析评估双层微生理系统中的灌注细胞培养条件
Micromachines (Basel). 2025 Mar 12;16(3):327. doi: 10.3390/mi16030327.
2
Intestinal Cells-on-Chip for Permeability Studies.用于渗透性研究的肠道芯片细胞
Micromachines (Basel). 2024 Nov 30;15(12):1464. doi: 10.3390/mi15121464.
3
A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia.
肾病成人及室上性心动过速儿科患者中纳多洛尔的综合生理学药代动力学模型。
Pharmaceuticals (Basel). 2024 Feb 19;17(2):265. doi: 10.3390/ph17020265.
4
Challenges in Permeability Assessment for Oral Drug Product Development.口服药物产品开发中渗透性评估的挑战。
Pharmaceutics. 2023 Sep 28;15(10):2397. doi: 10.3390/pharmaceutics15102397.
5
Models for barrier understanding in health and disease in lab-on-a-chips.用于在芯片实验室中理解健康与疾病状态下屏障的模型。
Tissue Barriers. 2024 Apr 2;12(2):2221632. doi: 10.1080/21688370.2023.2221632. Epub 2023 Jun 9.